<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>BioAgent Bench: An AI Agent Evaluation Suite for Bioinformatics - Health AI Hub</title>
    <meta name="description" content="This paper introduces BioAgent Bench, a novel evaluation suite and benchmark dataset for systematically measuring the performance and robustness of AI agents in">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>BioAgent Bench: An AI Agent Evaluation Suite for Bioinformatics</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2601.21800v1" target="_blank">2601.21800v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2026-01-29
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Dionizije Fa, Marko ƒåuljak, Bruno Pand≈æa, Mateo ƒåupiƒá
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.AI
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.90 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2601.21800v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2601.21800v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces BioAgent Bench, a novel evaluation suite and benchmark dataset for systematically measuring the performance and robustness of AI agents in complex, end-to-end bioinformatics tasks. It evaluates both closed-source and open-weight models, revealing that while agents can construct high-level pipelines, they often fail under controlled perturbations, underscoring critical weaknesses in step-level reasoning. The research also highlights the crucial trade-off between model performance and data privacy, advocating for open-weight models in sensitive clinical contexts despite lower completion rates.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research is crucial for medicine and health by providing a standardized method to assess the reliability and safety of AI agents intended for clinical bioinformatics, directly impacting areas like disease diagnostics, personalized medicine, and infectious disease surveillance where accurate 'omics data analysis is paramount.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>This research evaluates the performance and robustness of AI agents in processing and analyzing complex biological data critical for medical research and clinical applications. By benchmarking AI in tasks like variant calling and RNA-seq analysis, it directly contributes to the development and safe deployment of AI tools that can diagnose diseases, personalize treatments, monitor public health, and advance biomedical discovery, while also considering crucial aspects like patient data privacy and the reliability of AI outputs under various conditions.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>BioAgent Bench is a new benchmark dataset and evaluation suite for AI agents performing common bioinformatics tasks.</li>
                    
                    <li>The benchmark features curated end-to-end tasks (e.g., RNA-seq, variant calling, metagenomics) with explicit output artifact requirements for automated assessment.</li>
                    
                    <li>Evaluation includes stress testing under controlled perturbations (corrupted inputs, decoy files, prompt bloat) to assess AI agent robustness.</li>
                    
                    <li>Frontier closed-source and open-weight models were evaluated across multiple agent harnesses, with an LLM-based grader scoring pipeline progress and outcome validity.</li>
                    
                    <li>Agents can complete multi-step bioinformatics pipelines and produce requested artifacts reliably under ideal conditions, without extensive custom scaffolding.</li>
                    
                    <li>Robustness tests reveal significant failure modes in AI agents under perturbations, indicating that correct high-level pipeline construction does not guarantee reliable step-level reasoning.</li>
                    
                    <li>The study emphasizes that closed-source models are unsuitable for bioinformatics workflows involving sensitive patient data or proprietary IP due to privacy constraints, making open-weight models a preferable, though less performant, alternative in such settings.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The methodology involved developing BioAgent Bench, a dataset of curated end-to-end bioinformatics tasks requiring concrete output artifacts. Various frontier closed-source and open-weight AI models were evaluated across different agent harnesses. An LLM-based grader was employed to automatically score pipeline progress and the validity of generated outcomes. Stress testing was conducted by introducing controlled perturbations such as corrupted inputs, decoy files, and prompt bloat to assess model robustness.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>AI agents are capable of constructing and completing high-level bioinformatics pipelines and producing desired final artifacts without extensive custom scaffolding. However, these agents exhibit significant failure modes and a lack of reliable step-level reasoning when subjected to controlled perturbations like corrupted inputs or prompt bloat. Furthermore, the evaluation underscored that while closed-source models might offer higher completion rates, their use is problematic in scenarios involving sensitive patient data, making open-weight models a necessary, albeit less efficient, alternative under strict privacy constraints.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This benchmark facilitates the rigorous validation of AI agents for clinical applications, ensuring that 'omics analyses (e.g., genetic variant calling for disease diagnosis, metagenomics for pathogen identification) are both accurate and reliable. It provides a framework for healthcare providers and researchers to evaluate the suitability of AI solutions for tasks involving sensitive patient data, guiding decisions on model choice (open-weight vs. closed-source) to balance performance with privacy. By identifying robustness weaknesses, it also points towards critical areas for AI model improvement, preventing potential errors in clinical decision-making.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The study highlights key limitations of current AI agents, specifically their lack of robust step-level reasoning when faced with input perturbations, which can lead to pipeline failures. Additionally, a significant limitation identified is the unsuitability of closed-source AI models for bioinformatics workflows involving sensitive patient data due to strict privacy constraints.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>While not explicitly stated as future research directions in the abstract, the findings implicitly call for significant work in improving the robustness of AI agents in bioinformatics, particularly their step-level reasoning capabilities. The research also encourages the development and optimization of open-weight AI models that can reliably handle sensitive patient data while achieving competitive performance.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Genomics</span>
                    
                    <span class="tag">Transcriptomics</span>
                    
                    <span class="tag">Microbiology</span>
                    
                    <span class="tag">Precision Medicine</span>
                    
                    <span class="tag">Clinical Diagnostics</span>
                    
                    <span class="tag">Pathogen Surveillance</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">AI Agents</span>
                    
                    <span class="tag tag-keyword">Bioinformatics</span>
                    
                    <span class="tag tag-keyword">Benchmark</span>
                    
                    <span class="tag tag-keyword">RNA-seq</span>
                    
                    <span class="tag tag-keyword">Variant Calling</span>
                    
                    <span class="tag tag-keyword">Metagenomics</span>
                    
                    <span class="tag tag-keyword">Robustness</span>
                    
                    <span class="tag tag-keyword">LLM Evaluation</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">This paper introduces BioAgent Bench, a benchmark dataset and an evaluation suite designed for measuring the performance and robustness of AI agents in common bioinformatics tasks. The benchmark contains curated end-to-end tasks (e.g., RNA-seq, variant calling, metagenomics) with prompts that specify concrete output artifacts to support automated assessment, including stress testing under controlled perturbations. We evaluate frontier closed-source and open-weight models across multiple agent harnesses, and use an LLM-based grader to score pipeline progress and outcome validity. We find that frontier agents can complete multi-step bioinformatics pipelines without elaborate custom scaffolding, often producing the requested final artifacts reliably. However, robustness tests reveal failure modes under controlled perturbations (corrupted inputs, decoy files, and prompt bloat), indicating that correct high-level pipeline construction does not guarantee reliable step-level reasoning. Finally, because bioinformatics workflows may involve sensitive patient data, proprietary references, or unpublished IP, closed-source models can be unsuitable under strict privacy constraints; in such settings, open-weight models may be preferable despite lower completion rates. We release the dataset and evaluation suite publicly.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>